Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus type 1: Current status and prospects for the future
- 1 September 1991
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 91 (3) , S312-S319
- https://doi.org/10.1016/0002-9343(91)90388-e
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Risky Business: Using Necessarily Imprecise Casualty Counts to Estimate Occupational Risks for HIV-1 InfectionInfection Control & Hospital Epidemiology, 1990
- Failure of Zidovudine Prophylaxis after Accidental Exposure to HIV-1New England Journal of Medicine, 1990
- Suppression of HIV Infection in AZT-Treated SCID-hu MiceScience, 1990
- Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related DideoxynucleosidesNew England Journal of Medicine, 1989
- Prophylactic Zidovudine after Occupational Exposure to the Human Immunodeficiency Virus: An Interim AnalysisThe Journal of Infectious Diseases, 1989
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Suppression of mouse viraemia and retroviral disease by 3′-azido-3′-deoxythymidineNature, 1986